REVIEW article

Front. Cell Dev. Biol.

Sec. Signaling

Volume 13 - 2025 | doi: 10.3389/fcell.2025.1600596

This article is part of the Research TopicDeciphering Signaling Pathway Interactions in Tissue HomeostasisView all articles

Involvement of Role of HMGB1-NLRP3 Pathway in Systemic Disorders

Provisionally accepted
Lei  YangLei Yang1Xue  LiXue Li2Xiaoming  ZhuXiaoming Zhu2Futao  GeFutao Ge1Yuantao  WangYuantao Wang1*
  • 1First Affiliated Hospital of Jilin University, Changchun, China
  • 2The Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun, Jilin Province, China

The final, formatted version of the article will be published soon.

High mobility group box-1 (HMGB1) is a protein released from stressed or damaged cells that triggers immune activation and chronic inflammation. The NODlike receptor (NLR) family pyrin domain-containing 3 (NLRP3) is a central component of the inflammasome, which activates caspase-1 and releases pro-inflammatory cytokines, including IL-1β and IL-18. The HMGB1/NLRP3 axis plays a critical role in regulating inflammation and immune responses, driving systemic inflammation and disease progression. Targeting this pathway offers promising therapeutic strategies for conditions such as autoimmune disorders, trauma, and chronic inflammatory diseases.In particular, inhibiting HMGB1 or NLRP3 can mitigate the exaggerated inflammatory response, reduce tissue damage, and slow disease progression. This review explores the bidirectional interactions between HMGB1 and NLRP3 and discusses current and emerging therapeutic approaches targeting this axis to modulate inflammation and improve clinical outcomes.

Keywords: HMGB1, NLRP3, Inflammation, Systemic disorders, therapeutic targets

Received: 26 Mar 2025; Accepted: 20 Jun 2025.

Copyright: © 2025 Yang, Li, Zhu, Ge and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Yuantao Wang, First Affiliated Hospital of Jilin University, Changchun, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.